Sánchez María C, Luna Jose D, Barcelona Pablo F, Gramajo Ana L, Juarez Patricio C, Riera Clelia M, Chiabrando Gustavo A
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET)-Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, Argentina.
Exp Eye Res. 2007 Nov;85(5):644-50. doi: 10.1016/j.exer.2007.07.018. Epub 2007 Aug 6.
Panretinal photocoagulation (PRP) reduces the incidence of severe visual loss in proliferative diabetic retinopathy (PDR). The aim of the study was to determine the effect of PRP on the activity of matrix metalloproteinase-2 (MMP-2) and MMP-9, and also on the alpha(2)-Macroglobulin (alpha(2)M) proteolytic state in the vitreous of eyes with PDR. Vitreous samples were obtained from patients undergoing vitrectomy for the treatment of retinal diseases: 17 with PDR and eight with idiopathic macular hole (MH). Qualitative evaluation of the MMP-2 and MMP-9 activation status was performed by gelatin zymography and quantitative assay was carried out for vitreous total protein content and alpha(2)M. The proteolytic state of alpha(2)M was evaluated by Western blotting. Although all vitreous samples contained proMMP-2, increased proMMP-9 and active MMP-9 were detected in PDR samples without PRP. In addition, after PRP the proMMP-9 activity was significantly decreased, whereas the proMMP-2 activity was not affected. Enhanced total protein and alpha(2)M concentrations were observed in all vitreous samples from PDR patients with and without previous PRP compared with samples from patients with MH. However, a differential proteolytic state of alpha(2)M, expressed as 180/85-90kDa ratio, was detected among PDR patients with and without PRP treatment. Whereas a low 180/85-90kDa ratio of alpha(2)M in vitreous of PDR patients without PRP was observed, a high proportion of 180kDa subunit was principally detected in PDR with PRP. These results demonstrate that PDR occurs with an enhanced activity of MMP-9 and activation of alpha(2)M by proteinases, which is reversed after PRP. In addition, we suggest that alpha(2)M plays a key role in the control and regulation of the ocular neovascularization involved in the pathogenesis of ischemic retinal diseases such as PDR.
全视网膜光凝(PRP)可降低增殖性糖尿病视网膜病变(PDR)严重视力丧失的发生率。本研究的目的是确定PRP对PDR患者眼玻璃体内基质金属蛋白酶-2(MMP-2)和MMP-9活性以及α2-巨球蛋白(α2M)蛋白水解状态的影响。玻璃体样本取自因视网膜疾病接受玻璃体切除术的患者:17例PDR患者和8例特发性黄斑裂孔(MH)患者。通过明胶酶谱法对MMP-2和MMP-9的激活状态进行定性评估,并对玻璃体总蛋白含量和α2M进行定量测定。通过蛋白质印迹法评估α2M的蛋白水解状态。尽管所有玻璃体样本均含有前MMP-2,但在未接受PRP的PDR样本中检测到前MMP-9和活性MMP-9增加。此外,PRP后前MMP-9活性显著降低,而前MMP-2活性未受影响。与MH患者的样本相比,在接受和未接受过PRP的PDR患者的所有玻璃体样本中均观察到总蛋白和α2M浓度升高。然而,在接受和未接受PRP治疗的PDR患者中检测到α2M的蛋白水解状态存在差异,以180/85 - 90kDa比率表示。在未接受PRP的PDR患者玻璃体中观察到α2M的180/85 - 90kDa比率较低,而在接受PRP的PDR患者中主要检测到高比例的180kDa亚基。这些结果表明,PDR发生时MMP-9活性增强且蛋白酶激活α2M,PRP后这种情况会逆转。此外,我们认为α2M在控制和调节参与缺血性视网膜疾病(如PDR)发病机制的眼新生血管形成中起关键作用。